A. Al Jefri

发表

Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia.

H. Deeg, E. Guinan, B. George, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved Treatment Satisfaction and Convenience with Deferasirox in Iron-Overloaded Patients with β-Thalassemia: Results from the ESCALATOR Trial

A. Taher, A. El‐Beshlawy, Mohsen Saleh Elalfy, 2010, Acta Haematologica.

Advances in Allogeneic Stem Cell Transplantation for Hemoglobinopathies

A. Al Jefri, 2011, Hemoglobin.

Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2008-2009: report on behalf of the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group.

M. Aljurf, K. Alimoghaddam, A. Ghavamzadeh, 2011, Hematology/oncology and stem cell therapy.

Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes.

M. Shoukri, M. Ayas, S. Al Jumaah, 2011, Hematology/Oncology and Stem Cell Therapy.

HAX1 mutations causing severe congenital neuropenia and neurological disease lead to cerebral microstructural abnormalities documented by quantitative MRI

A. Schäffer, H. Lanfermann, C. Klein, 2010, American journal of medical genetics. Part A.

Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia: the ESCALATOR study

A. Taher, A. El‐Beshlawy, Mohsen Saleh Elalfy, 2009, European journal of haematology.

Second Allogeneic Bone Marrow Transplantation after Myeloablative Conditioning Analysis of 43 Cases from Single Institution

M. Aljurf, M. Ayas, M. Aslam, 2004, Hematology.

Multicenter Validation of Spin-Density Projection-Assisted R2-MRI for the Noninvasive Measurement of Liver Iron Concentration

Tim G St Pierre, Amal El-Beshlawy, Mohsen Elalfy, 2013, Magnetic resonance in medicine.

Achieving treatment goals of reducing or maintaining body iron burden with deferasirox in patients with β-thalassaemia: results from the ESCALATOR study

Amal El-Beshlawy, Abdullah Al Jefri, Kusai Al Zir, 2011, European journal of haematology.

Importance of optimal dosing ≥30 mg/kg/d during deferasirox treatment: 2.7-yr follow-up from the ESCALATOR study in patients with β-thalassaemia

Amal El-Beshlawy, Abdullah Al Jefri, Kusai Al Zir, 2011, European journal of haematology.

Extramedullary myeloid tumors in children: the limited value of local treatment.

R. Aur, M. Mustafa, M. Ayas, 2000, Journal of pediatric hematology/oncology.

HAX1 mutations causing severe congenital neuropenia and neurological disease lead to cerebral microstructural abnormalities documented by quantitative MRI

A. Schäffer, H. Lanfermann, C. Klein, 2010, American journal of medical genetics. Part A.